iDEL Therapeutics

iDEL Therapeutics

iDEL Therapeutics

Developing a pipeline of cancer therapeutics delivered directly into the cytosol of tumor cells.

2025ActiveDortmund, Germany

About

iDEL Therapeutics is a Dortmund-based startup focused on developing novel cancer therapeutics. Their core technology is a synthetic shuttle platform designed to deliver drugs directly into the cytosol of tumor cells, evading endosomal trapping and preventing degradation. This platform is compatible with both large and small molecules, including nanobodies and cytotoxic payloads, aiming to unlock historically undruggable intracellular targets and broaden therapeutic windows.

Signals agent

Reach companies that have budget right now

Every week the agent finds companies in your market that just got money or started hiring to spend it, and the person to talk to. You choose who to reach; nothing is sent for you.

  • Just raised a roundFresh budget, the week it lands
  • Hiring sales and marketingGo-to-market roles mean money to spend
  • Hiring fastA jump in open roles across the company
  • In the newsLaunches and announcements worth a message
  • The decision makerWho to contact, with a message you can edit

Is your startup an alternative to iDEL Therapeutics?

People comparing tools land here. Get listed beside these.

All funding rounds

Key facts

Website
idel-tx.com
Headquarters
Dortmund, Germany
Founded
2025
Founder
Marcus Kostka
Total funding
$10M (Seed)
Business model
B2B

Funding rounds

Funding rounds raised by iDEL Therapeutics
DateRoundAmountLead investors
17 Mar 2026Seed$10M

Tech stack

Detected on idel-tx.com, last scanned 1 Nov 2026.

Frontend
jQuery, Bootstrap
Analytics
Google Analytics 4
SEO
Yoast SEO
CMS / Builders
WordPress
Email provider
Microsoft 365

Benchmarking

See how your site ranks against 16,849 startups

iDEL Therapeutics sits in the 19th percentile for Domain Rating. Check where yours lands, free.

Check your Domain Rating

iDEL Therapeutics has a Domain Rating of 12, the 19th percentile of 16,849 startups we track.

Scores

Measured, not editorial

12

Measured by AhrefsAhrefs DR

Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.

Bottom 25%

Check yours
21

Measured by StartupHub.aiAgent Readiness

How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.

Bottom 25%

Scan yours
35

Measured by Google PageSpeedSite Speed

Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.

Bottom 25%

PageSpeed
69

Measured by StartupHub.aiData Trust

Whether this company is a safe place to put your data: security posture, privacy signals, and reputation evidence we could verify.

Above median

Measured by StartupHub.aiSecurity

What this company’s API or MCP server gives an anonymous stranger: transport, whether anything answers without credentials, CORS, response headers and, when an MCP server replies, which of its tools can be called with no key. Scanned live, on request, because a security verdict months old is worse than none.

Click to scan

Agent Readiness

Can AI agents use your site?

iDEL Therapeutics scores 21. Check yours free in a few seconds, or let Max Agent rerun it daily.

Run it daily with Max Agent
Median 41Across 23,755 scanned sites

AI visibility

Get read by ChatGPT, Claude and Perplexity

List your startup, then track where you show up in AI answers.

AI reads of this profile

Last 14 days, from server logs

Get notified when iDEL Therapeutics changes

Used iDEL Therapeutics? Write a review and get $5 in credits

Your first review on StartupHub.ai adds 1,250 credits to your account. Spend them on:

  • Email finder
  • Market Map Maker
  • Agent Readiness scans
  • Deep intel
  • Tech stack scans

Frequently asked

Is iDEL Therapeutics growing?

Yes, fast. Our data shows it raised $9.7M in a Seed in March 2026.

Are there companies like iDEL Therapeutics?

Yes. We list 6 companies like iDEL Therapeutics, including Moderna, Kite Pharma and Degron Therapeutics.

What does iDEL Therapeutics do?

The company is advancing two proprietary lead programs towards clinical evaluation, with a focus on addressing a range of solid tumors. iDEL Therapeutics also aims to create scalable value through partnerships.

Is iDEL Therapeutics trustworthy and reputable?

StartupHub's Data Trust & Reputation score for iDEL Therapeutics is 69 out of 100, a generally safe rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.

How much funding has iDEL Therapeutics raised?

iDEL Therapeutics has raised a total of $10M in funding. The most recent round on record is Seed.

SEC filings, insider activity, nonprofit links and pay benchmarks for iDEL Therapeutics:

Company details: from public sources. Funding: no announced round on file. Ownership: not yet claimed by the company. Scores: measured by named tools; each links to its method. Our rules

Categories

Need more than this profile? Deep intel researches any company website: team, funding, customers and tech.

Max Agent

Let Max Agent watch iDEL Therapeutics and its market for you

New competitors, funding rounds, pricing and product changes, and where you show up in AI answers, in one weekly report.

Free week

Starter listings, once

AI answers checked

Daily for 7 days

  • ChatGPT
  • Perplexity

Max Agent

$79 a month, or $9.99 with our badge on your site

AI answers checked

Every week

  • ChatGPT
  • Claude
  • Perplexity
  • Gemini